Accelerating the search for antimicrobial peptides with Google Antigravity
deepmind.google·2h ago
AI Engineering
MIT Technology Review·1d ago·5 min read
The US military’s race to make fake blood
TL;DR
The US military is developing synthetic blood products to address battlefield injuries and improve survival rates. This innovation aims to provide a reliable alternative to traditional blood transfusions in combat situations.
✦ Why It Matters
Explore partnerships with biotech firms to accelerate the development of synthetic blood solutions for emergency medical applications.
Key Takeaways
- Investigate synthetic blood technologies for potential applications in emergency medicine.
- Consider collaborations with DARPA for research funding opportunities.
- Stay informed on FDA regulations affecting synthetic blood products.
- Explore advancements in lipid nanoparticles for drug delivery systems.
How It Works
ErythroMer uses a lipid nanoparticle to encapsulate hemoglobin, allowing for stable storage and effective oxygen delivery without the complications of traditional blood transfusions. SynthoPlate employs specialized peptides to mimic natural platelet functions, enhancing clotting and reducing bleeding time.